
|Articles|September 2, 2010
Cerebrovascular Disease Medications
Advertisement
Aspirin, Extended-Release Dipyridamole (Aggrenox)
Simvastatin
Isoxsuprine Hcl (Vasodilan)
Advertisement
Related Content
Advertisement


AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
Published: | Updated:



Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears Wave Neuroscience MeRT System for PTSD
2
AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
3
ACS Colorectal Cancer Screening Update: Implications for Primary Care
4
7 Late-Breaking Clinical Trials to Watch For at SLEEP 2026
5





































































































































































